Neoadjuvant chemotherapy response influences outcomes in non-colorectal, non-neuroendocrine liver metastases.
CONCLUSION: The prognosis of patients with NCNNE liver metastases is influenced by preoperative chemotherapy and resectability.
PMID: 29893476 [PubMed - as supplied by publisher]
Source: The British Journal of Surgery - Category: Surgery Authors: Lucchese AM, Kalil AN, Ruiz A, Karam V, Ciacio O, Pittau G, Castaing D, Cherqui D, Sa Cunha A, Vibert E, Adam R Tags: Br J Surg Source Type: research
More News: Brain | Chemotherapy | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Neurosurgery | Study | Surgery | UK Health | Urology & Nephrology